Title MD

Title MD operates as a physician-led medical spa with locations in Manhattan and Queens, New York, where medical director Stacy F. Title, M.D. oversees clinical protocols for medical weight control and facial aesthetics. The practice integrates prescription weight loss pharmacotherapy with cosmetic dermatology procedures, providing patients access to both metabolic management and appearance-focused treatments under physician supervision. Dr. Title's medical oversight ensures that weight loss interventions follow evidence-based protocols appropriate for patients with obesity or metabolically complicated weight management needs.

The clinic's medical weight control program centers on semaglutide, a GLP-1 receptor agonist peptide approved for chronic weight management in adults with elevated BMI or weight-related comorbidities. Semaglutide functions by mimicking incretin hormones that regulate appetite and glucose metabolism, leading to reduced caloric intake through enhanced satiety signaling. Title MD administers semaglutide via subcutaneous injection on a prescribed dosing schedule, with treatment plans individualized based on patient response, tolerance, and weight loss objectives. The medical team monitors patients throughout treatment to adjust dosing, address side effects, and coordinate care with existing healthcare providers when patients have concurrent metabolic conditions such as prediabetes or hypertension.

Dr. Stacy F. Title brings her medical degree and clinical experience to patient consultations, conducting initial assessments that include medical history review, body composition analysis, and discussion of realistic weight loss timelines. Her approach emphasizes the distinction between cosmetic weight loss and medically necessary weight reduction for patients with obesity-related health risks. The practice's dual focus allows patients to address both metabolic health through peptide therapy and aesthetic concerns through dermatologic procedures, creating coordinated treatment plans when patients seek comprehensive body contouring or facial rejuvenation alongside weight management.

Patients at Title MD locations in Manhattan and Queens begin with an in-person consultation where eligibility for semaglutide is determined based on BMI criteria, contraindications, and treatment goals. The clinic provides instruction on self-administration technique for at-home injections, supplies necessary injection materials, and schedules follow-up appointments to track progress and modify treatment parameters. Patients receive guidance on nutrition strategies that complement GLP-1 therapy, as the medication's appetite-suppressing effects work synergistically with caloric restriction. The practice maintains communication channels for patients to report adverse effects or ask questions between scheduled visits, ensuring medical supervision throughout the treatment course.

With a 4.9-star rating across 176 Google reviews, Title MD has established a patient base in New York City's competitive medical aesthetics market. The practice's Manhattan location serves patients throughout the five boroughs and surrounding areas, while the Queens office provides access for residents in eastern New York City neighborhoods. By combining physician-directed peptide therapy for weight loss with aesthetic dermatology services, Title MD addresses the overlapping patient population seeking both metabolic improvement and cosmetic enhancement under unified medical supervision in New York.